Confidential client
N/AOUTCOME: Ongoing
Representation of a pharmaceutical sales executive targeted in a federal investigation involving allegations of off-label promotion and anti-kickback violations.
Boston, MA
White collar crime Lawyer at Boston, MA
Practice Areas: White Collar Crime, Health Care, Life Sciences & Biotechnology
OUTCOME: Ongoing
Representation of a pharmaceutical sales executive targeted in a federal investigation involving allegations of off-label promotion and anti-kickback violations.
OUTCOME: Ongoing
Representation of multiple institutional dialysis providers in a federal investigation of alleged Medicaid billing violations.
OUTCOME: Ongoing
Representation of the owner of multiple skilled nursing facilities in a federal investigation involving Medicare billing issues.
OUTCOME: Settled on favorable terms
Representation of a major pharmaceutical manufacturer in an investigation by the Massachusetts Attorney General’s Office involving potential violations of state gift ban and payment reporting regulatio ... ns.
OUTCOME: Ongoing
Representation of a national hospital chain in connection with the federal investigation of the New England Compounding Center and the multistate outbreak of fungal meningitis.
OUTCOME: Some cases resolved on favorable terms; some ongoing
Representation of various pharmaceutical manufacturers in average wholesale price (“AWP”) multidistrict litigation and AWP lawsuits brought by various state attorneys general.
OUTCOME: Voluntary disclosure and repayment accepted without further investigation or litigation.
Representation of a Massachusetts teaching hospital in connection with its voluntary disclosure of Medicare overpayments associated with patients who received observation services.
OUTCOME: Government investigations resolved as part of a global $3 billion criminal and civil settlement with the federal government and certain participating states, the largest health care fraud settlement in U.S. history.
Representation of a major pharmaceutical manufacturer in two separate government investigations involving alleged off-label promotion, anti-kickback violations, and improper “Best Price” reporting unde ... r the Medicaid Drug Rebate Program.